David B Buller1, Abigail Halperin, Herbert H Severson, Ron Borland, Michael D Slater, Erwin P Bettinghaus, David Tinkelman, Gary R Cutter, William Gill Woodall. 1. Klein Buendel, Inc, Golden, Colorado (Drs Buller and Bettinghaus); Department of Family Medicine, University of Washington, Seattle (Dr Halperin); Oregon Research Institute, Eugene (Dr Severson); Cancer Council Victoria, Carlton South, Victoria, Australia (Dr Borland); School of Communication, Ohio State University, Columbus (Dr Slater); National Jewish Health, Denver, Colorado (Dr Tinkelman); School of Public Health, University of Alabama at Birmingham (Dr Cutter); and Center on Alcoholism, Substance Abuse, and Addictions, University of New Mexico, Albuquerque (Dr Woodall).
Abstract
CONTEXT: Young adult smokers have the highest smoking prevalence among all US age groups but are least likely to use evidence-based cessation counseling or medication to quit. OBJECTIVE: Use and effectiveness of nicotine patch were explored in a randomized trial evaluating smoking cessation interventions with this population. PARTICIPANTS: Smokers aged 18 to 30 (n = 3094) were recruited through online and off-line methods and from telephone quit lines and analyzed. DESIGN: Smokers were enrolled in a pretest-posttest trial, and randomized to 1 of 3 cessation services. SETTING: Trial delivering counseling services by self-help booklet, telephone quit lines, or online expert system in the 48 continental United States. INTERVENTION: Smokers could request a free 2-week course of nicotine replacement therapy (NRT) patches from the project. MAIN OUTCOME MEASURE: Follow-up surveys at 12 and 26 weeks assessed smoking abstinence, use of NRT, counseling, and other cessation medications, and smoking-related variables. RESULTS: Overall, 69.0% of smokers reported using NRT (M = 3.2 weeks) at 12 weeks and 74.8% (M = 3.3 weeks) at 26 weeks. More smokers who were sent the free nicotine patches (n = 1695; 54.8%) reported using NRT than those who did not receive them (12 weeks: 84.3% vs 41.9%, P < .001; 26 weeks: 87.6% vs 51.1%, P < .001). The use of NRT was associated with greater smoking abstinence at 12 weeks (P < .001) and 26 weeks (P < .05), especially if used for more than 2 weeks (P < .001). Smokers assigned to a self-help booklet or cessation Web site and heavier smokers were most likely to use NRT (P < .05), whereas those reporting marijuana use and binge drinking used NRT less (P < .05). CONCLUSIONS:Many young adults were willing to try NRT, and it appeared to help them quit in the context of community-based cessation services. Strategies should be developed to make NRT available to this age group and support them in using it to prevent lifelong smoking.
RCT Entities:
CONTEXT: Young adult smokers have the highest smoking prevalence among all US age groups but are least likely to use evidence-based cessation counseling or medication to quit. OBJECTIVE: Use and effectiveness of nicotine patch were explored in a randomized trial evaluating smoking cessation interventions with this population. PARTICIPANTS: Smokers aged 18 to 30 (n = 3094) were recruited through online and off-line methods and from telephone quit lines and analyzed. DESIGN: Smokers were enrolled in a pretest-posttest trial, and randomized to 1 of 3 cessation services. SETTING: Trial delivering counseling services by self-help booklet, telephone quit lines, or online expert system in the 48 continental United States. INTERVENTION: Smokers could request a free 2-week course of nicotine replacement therapy (NRT) patches from the project. MAIN OUTCOME MEASURE: Follow-up surveys at 12 and 26 weeks assessed smoking abstinence, use of NRT, counseling, and other cessation medications, and smoking-related variables. RESULTS: Overall, 69.0% of smokers reported using NRT (M = 3.2 weeks) at 12 weeks and 74.8% (M = 3.3 weeks) at 26 weeks. More smokers who were sent the free nicotine patches (n = 1695; 54.8%) reported using NRT than those who did not receive them (12 weeks: 84.3% vs 41.9%, P < .001; 26 weeks: 87.6% vs 51.1%, P < .001). The use of NRT was associated with greater smoking abstinence at 12 weeks (P < .001) and 26 weeks (P < .05), especially if used for more than 2 weeks (P < .001). Smokers assigned to a self-help booklet or cessation Web site and heavier smokers were most likely to use NRT (P < .05), whereas those reporting marijuana use and binge drinking used NRT less (P < .05). CONCLUSIONS: Many young adults were willing to try NRT, and it appeared to help them quit in the context of community-based cessation services. Strategies should be developed to make NRT available to this age group and support them in using it to prevent lifelong smoking.
Authors: Susan L Kenford; David W Wetter; Samuel K Welsch; Stevens S Smith; Michael C Fiore; Timothy B Baker Journal: Addict Behav Date: 2005-02 Impact factor: 3.913
Authors: Nancy Miller; Thomas R Frieden; Sze Yan Liu; Thomas D Matte; Farzad Mostashari; Deborah R Deitcher; K Michael Cummings; Christina Chang; Ursula Bauer; Mary T Bassett Journal: Lancet Date: 2005 May 28-Jun 3 Impact factor: 79.321
Authors: K Michael Cummings; Brian Fix; Paula Celestino; Shannon Carlin-Menter; Richard O'Connor; Andrew Hyland Journal: J Public Health Manag Pract Date: 2006 Jan-Feb
Authors: Joseph E Bauer; Shannon M Carlin-Menter; Paula B Celestino; Andrew Hyland; K Michael Cummings Journal: J Public Health Manag Pract Date: 2006 Jan-Feb
Authors: K Michael Cummings; Andrew Hyland; Brian Fix; Ursula Bauer; Paula Celestino; Shannon Carlin-Menter; Nancy Miller; Thomas R Frieden Journal: Am J Prev Med Date: 2006-06-12 Impact factor: 5.043
Authors: Beti Thompson; Gloria Coronado; Lu Chen; L Anne Thompson; Abigail Halperin; Robert Jaffe; Tim McAfee; Susan M Zbikowski Journal: Nicotine Tob Res Date: 2007-03 Impact factor: 4.244
Authors: Susan J Curry; Amy K Sporer; Oksana Pugach; Richard T Campbell; Sherry Emery Journal: Am J Public Health Date: 2007-06-28 Impact factor: 9.308
Authors: Lawrence C An; Barbara A Schillo; Annette M Kavanaugh; Randi B Lachter; Michael G Luxenberg; Ann H Wendling; Anne M Joseph Journal: Tob Control Date: 2006-08 Impact factor: 7.552
Authors: Susan H Swartz; Timothy M Cowan; Joan E Klayman; MaryBeth T Welton; Barbara A Leonard Journal: Am J Prev Med Date: 2005-11 Impact factor: 5.043
Authors: Thomas R Fanshawe; William Halliwell; Nicola Lindson; Paul Aveyard; Jonathan Livingstone-Banks; Jamie Hartmann-Boyce Journal: Cochrane Database Syst Rev Date: 2017-11-17